ConCallIQ
Go Pro
GODAVARIBIOREFINERIES Diversified 10 Feb 2026

Godavari Biorefineries Ltd — Q3 FY26

Godavari Biorefineries delivered a mixed Q3 FY26 with modest revenue growth of 2.5% YoY to ₹461.9 Cr, but strong profitability improvement as EBITDA grew 13.8% YoY to ₹45.1 Cr and margins expanded 97 bps to 9.8%.

bullish medium
Compare with...
Revenue ₹462 Cr +2.5%
EBITDA ₹45 Cr +13.8%
PAT ₹8 Cr
EBITDA Margin 9.8% +97bps
Duration 53 min
Read Time 1 min read

✓ Verified against BSE filing

2-Minute Summary

✦ AI-Generated from Full Transcript

Godavari Biorefineries delivered a mixed Q3 FY26 with modest revenue growth of 2.5% YoY to ₹461.9 Cr, but strong profitability improvement as EBITDA grew 13.8% YoY to ₹45.1 Cr and margins expanded 97 bps to 9.8%. The bio-based chemicals segment drove margin expansion, with its EBITDA margin improving to 7.7% from 4.5% last year, supported by a higher share of specialty products. Ethanol faced margin pressure due to rising cane costs and unchanged government pricing, but management is mitigating this via multi-feedstock flexibility and ENA sales. The consumer brand Jivana crossed ₹100 Cr revenue in 9M FY26, with distribution reaching 7,500+ outlets. Key risks include further delay in the grain-based distillery commissioning (now expected next quarter) and lack of government ethanol price revision, which could pressure ethanol margins. Management reiterated its target to 3x EBITDA by FY29 through capex of ₹25 Cr, with 75% allocated to bio-based chemicals.

Risks3 trackedTranscriptfull text
Research workspace

Focused Modules

!Risks 3 risks

Risk Intelligence

Ethanol price stagnation vs rising cane costs

View Risks →
Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

Bio-based chemicals EBITDA margin 7.7%
+320bps YoY

Improved from 4.5% in Q3 FY25, driven by higher specialty product share.

Consumer brand Jivana revenue (9M FY26) ₹100 Cr
N/A

Crossed ₹100 Cr milestone in first 9 months, validating B2C strategy.

Retail outlets for Jivana 7,500+
+500 QoQ

Expanded from 7,000+ in previous quarter, growing distribution reach.

Finance cost decline 48%
-48% YoY

Declined 48% YoY, reflecting improved cash flows and balance sheet strength.

Fast read

Guidance and risk preview

Top guidance 3x EBITDA by FY29

Management targets tripling EBITDA over 4 years from FY25 base, with capex of ₹25 Cr allocated 75% to bio-based chemicals and 25% to ethanol.

Top risk Ethanol price stagnation vs rising cane costs

Government has not revised ethanol prices for 2-3 years while cane costs have risen, pressuring ethanol margins.

View Risks →